Back to David Rubenstein
David Rubenstein → ACET via Carlyle Group Inc.
David Rubenstein ACET Position History
Adicet Bio, Inc.
Quarters held
12
Latest value
$1.6M
Q2 2026
Peak value
$12.2M
First seen
Q1 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.6M | 184.3K | — | — |
| Q3 2025 | $2.4M | 2.95M | — | — |
| Q2 2025 | $1.8M | 2.95M | — | — |
| Q1 2025 | $2.3M | 2.95M | — | — |
| Q4 2024 | $2.8M | 2.95M | — | — |
| Q3 2024 | $4.2M | 2.95M | — | — |
| Q2 2024 | $3.6M | 2.95M | — | — |
| Q1 2024 | $6.9M | 2.95M | — | — |
| Q4 2023 | $4M | 2.12M | — | — |
| Q3 2023 | $2.9M | 2.12M | — | — |
| Q2 2023 | $5.1M | 2.12M | — | — |
| Q1 2023 | $12.2M | 2.12M | — | — |